#including global#Regulatory snapshots#global drug#drug submissions#Regulatory actions
#Biopharma happenings#including deals#Actimed#Anaptysbio#GSK
#III Alzheimer#phase III#semaglutide fails#Nov.#III
#Nov. 17-21#ICYMI#top stories#Week#Nov.
#Nov. 17-21#biopharma stock#Biggest gainers#stock gainers#losers
#Nov. 17-21#med-tech stock#Med-tech gainers#stock gainers#Med-tech
#coronavirus pandemic#ongoing coverage#BioWorld coronavirus#coronavirus articles#Free access
#HHS Secretary#Secretary Robert#placing HHS#CDC alters#CDC website